drug
ciclesonide
Marketedupdated 5mo agoby Covis Pharmaceuticals Inc (Inactive)
Approvedcommunity read0 votes
indications
investigational
Asthma
all catalysts(0)
nothing on the calendar yet
Trials studying ciclesonide
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 1, 2028
~1.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Feb 1, 2028method-of-use (U-1355)US 83712921.3y
- Feb 1, 2028method-of-use (U-1356)US 83712921.3y
- Feb 1, 2028method-of-use (U-1357)US 83712921.3y
- Feb 1, 2028method-of-use (U-1355)US 83712921.3y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that